;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Dermatology play Dermira raises $51 million in series C

    Dermira Inc. (Redwood City, Calif.) raised $51 million in a series C round and announced a number of management changes and board appointments. The C round came from existing investors Bay City Capital; New Enterprise …

    Published on 8/19/2014
  • FINANCIAL NEWS: HealthQuest raises $110M for initial fund

    HealthQuest Capital raised $110 million for its debut fund, more than doubling its initial $50 million target. The fund will invest in the medical device, diagnostic, patient care product, consumer health/OTC and …

    Published on 8/19/2014
  • FINANCIAL NEWS: Chugai rises on Roche rumors

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) jumped Y510 (15%) to Y3,825 on Monday on reports that parent company Roche (SIX:ROG; OTCQX:RHHBY) is looking to buy the 40% of Chugai it does not already own. The Japanese …

    Published on 8/18/2014
  • FINANCIAL NEWS: Indian dermatology play Vyome closes B round

    Vyome Biosciences (New Delhi, India) raised an undisclosed amount in the first tranche of a Rs500 million ($8.2 million) series B round led by new investor Sabre Partners. Existing investors Aarin Capital and Navam …

    Published on 8/18/2014
  • FINANCIAL NEWS: Nirmidas raises $2 million in seed round

    Nirmidas Biotech Inc. (San Francisco, Calif.) raised $2 million in a seed round from an undisclosed VC firm, a life science angel investor and Stanford StartX. The funds will be used to commercialize Nirmidas' pGOLD …

    Published on 8/18/2014
  • FINANCIAL NEWS: NeoGenomics raises $32.2 in follow-on

    NeoGenomics Inc. (NASDAQ:NEO) raised $32.2 million through the sale of 7 million shares at $4.60 per share in a follow-on underwritten by William Blair; Craig-Hallum Capital; Stephens; Roth Capital Partners; Sidoti; and…

    Published on 8/15/2014
  • FINANCIAL NEWS: ProQR files for IPO

    ProQR Therapeutics B.V. (Leiden, the Netherlands) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Leerink Partners; Deutsche Bank; JMP Securities; and H.C. Wainwright. ProQR's QR-10, an RNA-based …

    Published on 8/15/2014
  • FINANCIAL NEWS: Santhera raises $14.8 million selling treasury shares

    Santhera Pharmaceuticals Holding AG (SIX:SANN) raised CHF13.4 million ($14.8 million) through the sale of 200,000 treasury shares at an average price of CHF 66.85. The company said the shares were sold over the past …

    Published on 8/15/2014
  • FINANCIAL NEWS: Foamix files for IPO

    Israeli dermatology play Foamix Pharmaceuticals Ltd. (Ness Ziona, Israel) filed to raise up to $74.8 million in an IPO on NASDAQ underwritten by Barclays; Cowen; Oppenheimer; and Maxim Group. By mid-2015, Foamix plans …

    Published on 8/14/2014
  • FINANCIAL NEWS: NeoGenomics planning follow-on

    NeoGenomics Inc. (NASDAQ:NEO) proposed a follow-on late Thursday underwritten by William Blair; Craig-Hallum Capital; Stephens; Roth Capital Partners; Sidoti; and Dawson James Securities. NeoGenomics, which markets next…

    Published on 8/14/2014
  • FINANCIAL NEWS: Retroscreen raises L33.6 million

    Retroscreen Virology Group plc (LSE:RVG) raised L33.6 million ($56.4 million) through the sale of 12.9 million shares at 260p in a placing with existing and new institutional investors. The price is a 19% discount to …

    Published on 8/14/2014
  • FINANCIAL NEWS: Celladon raises $38 million in follow-on

    Gene therapy play Celladon Corp. (NASDAQ:CLDN) raised $38 million through the sale of 4 million shares at $9.50 in a follow-on underwritten by Credit Suisse; Jefferies; Stifel; and Wedbush PacGrow. Celladon said it …

    Published on 8/13/2014
  • FINANCIAL NEWS: Insmed raises $100.1 million in bumped-up offering

    Insmed Inc. (NASDAQ:INSM) raised $100.1 million through the sale of 8.9 million shares at $11.25 in a bumped-up follow-on underwritten by Leerink; Piper Jaffray; JMP Securities; and H.C. Wainwright. Insmed proposed to …

    Published on 8/13/2014
  • FINANCIAL NEWS: Ligand raises $225 million in note deal

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) raised $225 million through the sale of unsecured convertible senior notes to institutional buyers. The notes bear interest at 0.75%, mature on Aug. 15, 2019 and initially …

    Published on 8/13/2014
  • FINANCIAL NEWS: Otonomy raises $100 million in IPO

    Otonomy Inc. (NASDAQ:OTIC) was up $1.15 to $17.15 on its first day of trading Wednesday after raising $100 million through the sale of 6.3 million shares at $16 in an IPO. The price values the company at $325.4 million.…

    Published on 8/13/2014
  • FINANCIAL NEWS: Vitae files for IPO

    Vitae Pharmaceuticals Inc. (Fort Washington, Pa.) filed to raise up to $55 million in an IPO on NASDAQ underwritten by Stifel; BMO Capital Markets; JMP Securities; and Wedbush PacGrow. Vitae's lead compound, VTP-34072, …

    Published on 8/13/2014
  • FINANCIAL NEWS: Aegerion raises $300M in bumped-up note deal

    Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) raised $300 million through the sale of senior convertible notes due 2019 to institutional investors. The notes bear 2% interest and initially convert at $41.18, a 30% premium…

    Published on 8/12/2014
  • FINANCIAL NEWS: Dendreon's debt too deep

    Dendreon Corp. (NASDAQ:DNDN) crashed $0.72 (34%) to $1.40 on Tuesday after disclosing late Monday that there is a significant risk the company will not be able to repay or refinance the $620 million in unsecured notes …

    Published on 8/12/2014
  • FINANCIAL NEWS: DRI acquires royalty rights to Ampyra for $42M

    DRI Capital's private equity fund Drug Royalty III acquired worldwide royalty rights to multiple sclerosis drug Ampyra dalfampridine from Rush University Medical Center for about $42 million. In 2013, DRI Capital closed…

    Published on 8/12/2014
  • FINANCIAL NEWS: GeNO pulls IPO

    GeNO LLC (Cocoa, Fla.) withdrew its IPO on NASDAQ. GeNO did not provide a reason in its SEC filing and did not respond in time for publication. Last November, the company filed to raise up to $50 million in an offering …

    Published on 8/12/2014
  • FINANCIAL NEWS: Orthocell slips in ASX trading debut

    Regenerative medicine play Orthocell Ltd. (ASX:OCC) was off A$0.04 to A$0.36 in its first day of trading on the ASX on Tuesday. Last month, Orthocell raised A$8 million ($7.5 million) through the sale of 20 million …

    Published on 8/12/2014
  • FINANCIAL NEWS: Oxford Nanopore raises $58M

    Oxford Nanopore Technologies Ltd. (Oxford, U.K.) raised £35 million ($58.8 million) in a private placement to new and existing investors in the U.K., U.S. and mainland Europe. New investors participating in the …

    Published on 8/12/2014
  • FINANCIAL NEWS: Tokai files for IPO

    Cancer play Tokai Pharmaceuticals Inc. (Cambridge, Mass.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by BMO Capital Markets; Stifel; William Blair; and Janney Montgomery Scott. Tokai's galeterone …

    Published on 8/12/2014
  • FINANCIAL NEWS: Aegerion to raise $250M in notes

    Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) said it plans to raise $250 million through the sale of senior convertible notes due in 2019. Last month, the company reported $36 million in 2Q14 net product sales of …

    Published on 8/11/2014
  • FINANCIAL NEWS: Danish Forward Pharma files for IPO

    Forward Pharma A/S (Copenhagen, Denmark) filed to raise up to $200 million in an IPO on NASDAQ underwritten by Leerink Partners. The company expects to trade under the symbol "FWP." Forward Pharma's lead product is …

    Published on 8/11/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993